Counselling Framework for Germline <i>BRCA1/2</i> and <i>PALB2</i> Carriers Considering Risk-Reducing Mastectomy
Female <i>BRCA1/2</i> and <i>PALB2</i> germline pathogenic variant carriers have an increased lifetime risk of breast cancer and may wish to consider risk-reducing mastectomy (RRM) for surgical prevention. Quantifying the residual lifetime risk and absolute benefit from RRM r...
Main Authors: | Stephanie M. Wong, Carla Apostolova, Elisheva Eisenberg, William D. Foulkes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/31/1/23 |
Similar Items
-
Satisfaction and Quality of Life of Healthy and Unilateral Diseased <i>BRCA1/2</i> Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire
by: Natalie Herold, et al.
Published: (2022-07-01) -
Comparing Prognosis for <i>BRCA1</i>, <i>BRCA2</i>, and Non-BRCA Breast Cancer
by: Pedro Antunes Meireles, et al.
Published: (2023-12-01) -
Nipple Sparing Mastectomy as a Risk-Reducing Procedure for <i>BRCA</i>-Mutated Patients
by: Nicola Rocco, et al.
Published: (2021-02-01) -
Non-Coding Variants in <i>BRCA1</i> and <i>BRCA2</i> Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
by: Elizabeth Santana dos Santos, et al.
Published: (2018-11-01) -
<i>BRCA1/2</i> Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome
by: Trong-Nhan N. Le, et al.
Published: (2022-01-01)